乳腺癌免疫治疗新策略

被引：13

作者：

虞林玉 ^{[1
,2
]}

李慕鹏 ^{[1
,2
]}

旷达彬 ^{[1
,2
]}

张聪敏 ^{[1
,2
]}

陈小平 ^{[1
,2
]}

机构：

[1] 中南大学湘雅医院临床药理研究所

[2] 中南大学临床药理研究所遗传药理学湖南省重点实验室

来源：

中国药理学通报 | 2016年 / 32卷 / 08期

关键词：

乳腺癌; 免疫治疗; 肿瘤疫苗; 双特异性抗体; 检查点抑制剂; 共刺激分子; 细胞因子治疗;

D O I：

暂无

中图分类号：

R737.9 [乳腺肿瘤];

学科分类号：

100214 [肿瘤学];

摘要：

乳腺癌是女性最常见的恶性肿瘤,目前乳腺癌治疗以包括手术治疗、化疗、放疗、内分泌治疗、靶向治疗在内的综合治疗为主。随着细胞生物学、分子生物学、免疫学的发展,免疫治疗成为乳腺癌治疗的新领域。该文对肿瘤疫苗、双特异性抗体、检查点抑制剂及共刺激分子激动剂等乳腺癌免疫治疗新策略进行综述。

引用

页码：1037 / 1040

页数：4

共 9 条

[1]

SAHA和TRAIL联合使用对乳腺癌雌激素受体阳性细胞MCF-7生长的影响 [J].

韩翰 ;

王敏 .

中国药理学通报, 2016, 32 (02) :223-228

[2]

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management [J].

Sgambato, Assunta ;

Casaluce, Francesca ;

Sacco, Paola C. ;

Palazzolo, Giovanni ;

Maione, Paolo ;

Rossi, Antonio ;

Ciardiello, Fortunato ;

Gridelli, Cesare .

CURRENT DRUG SAFETY, 2016, 11 (01) :62-68

[3]

Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein [J].

Cai, Hui ;

Degliangeli, Federica ;

Palitzsch, Bjoern ;

Gerlitzki, Bastian ;

Kunz, Horst ;

Schmitt, Edgar ;

Fiammengo, Roberto ;

Westerlind, Ulrika .

BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (05) :1132-1135

[4]

Anti-PD-L1 for metastatic triple-negative breast cancer [J].

Gibson, Josefine .

LANCET ONCOLOGY, 2015, 16 (06) :E264-E264

[5]

Global Cancer Statistics, 2012 [J].

Torre, Lindsey A. ;

Bray, Freddie ;

Siegel, Rebecca L. ;

Ferlay, Jacques ;

Lortet-Tieulent, Joannie ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (02) :87-108

[6]

Formulation and Stability of Cytokine Therapeutics [J].

Lipiainen, Tiina ;

Peltoniemi, Marikki ;

Sarkhel, Sanjay ;

Yrjonen, Teijo ;

Vuorela, Heikki ;

Urtti, Arto ;

Juppo, Anne .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (02) :307-326

[7]

Tremelimumab: a review of development to date in solid tumors [J].

Tarhini, Ahmad A. .

IMMUNOTHERAPY, 2013, 5 (03) :215-229

[8]

AE37: a novel T-cell-eliciting vaccine for breast cancer [J].

Sears, Alan K. ;

Perez, Sonia A. ;

Clifton, Guy T. ;

Benavides, Linda C. ;

Gates, Jeremy D. ;

Clive, Kevin S. ;

Holmes, Jarrod P. ;

Shumway, Nathan M. ;

Van Echo, David C. ;

Carmichael, Mark G. ;

Ponniah, Sathibalan ;

Baxevanis, Constantin N. ;

Mittendorf, Elizabeth A. ;

Papamichail, Michael ;

Peoples, George E. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (11) :1543-1550

[9]

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers [J].

Svane, Inge Marie ;

Pedersen, Anders E. ;

Johansen, Julia S. ;

Johnsen, Hans E. ;

Nielsen, Dorte ;

Kamby, Claus ;

Ottesen, Svend ;

Balslev, Eva ;

Gaarsdal, Eva ;

Nikolajsen, Kirsten ;

Claesson, Mogens H. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (09) :1485-1499

← 1 →